Drug · DIN 02499835
TUKYSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 24, 2025; first marketed August 27, 2020.
- Drug Identification Number (DIN)
- 02499835
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tucatinib L01EH03
- Class
- Human
- Record last updated
- November 27, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TUCATINIB | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 24, 2025: NOC 36417New Drug Submission (NDS) · Administrative: Change in product ownership
- July 9, 2021: NOC 26246New Drug Submission (NDS) · Manufacturer name change
- June 5, 2020: NOC 23735New Drug Submission (NDS)
Other DINs named TUKYSA
- DIN 02499827 · Marketed